Akums Drugs IPO: निवेश करना सही है?

Published 31st July 2024 By: Value Research Dhanak

क्या करती है Akums Drugs

[{"selector":"#anim-c28b7534-7a4c-4fb4-8c9e-4b61e4ee5421 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(0%, 0, 0) translate(25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-561c1744-e379-4df2-96a0-d696f2f8a93c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-58f3bade-874f-4a8a-b248-5fdf24aa4276","keyframes":{"transform":["translate3d(-115.50632%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-293e8819-6b84-4c3d-9d5c-7bd04055b139","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ccfa2d95-b5c2-4bcd-927b-93f8bd7fbfb8","keyframes":{"transform":["translate3d(-116.13924%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] साल 2004 में वज़ूद में आई 'Akums Drugs' एक फ़ार्मास्युटिकल कॉन्ट्रैक्ट डेवलपमेंट एंड मैन्युफैक्चरिंग ऑर्गनाइजेशन (CDMO) है. भारत में 11 मैन्युफैक्चरिंग फैसिलिटी ऑपरेट करने वाली ये कंपनी, रेवेन्यू और प्रोडक्शन कैपेसिटी के मामले में सबसे बड़ी इंडिया-फ़ोकस्ड CDMO है.

Akums Drugs IPO की डिटेल

[{"selector":"#anim-151e05a3-ee30-4480-9abc-870c19a0f8cb","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7abe6ab1-f707-4c0c-9990-2344b2a1f364","keyframes":{"transform":["translate3d(-115.82278%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ba665715-c5fc-4c0d-853d-25364e4e6252","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-67afbe8c-d8b7-4d3d-b58c-343f809518b2","keyframes":{"transform":["translate3d(-112.08459%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] IPO का कुल साइज़ (करोड़ ₹) 1857 ऑफर फॉर सेल (करोड़ ₹) 1177 नए इशू (करोड़ ₹) 680 प्राइस बैंड (₹) 646 - 679 सब्सक्रिप्शन की तारीख़ 30 जुलाई 2024 से 1 अगस्त 2024 तक उद्देश्य क़र्ज़ चुकाने, संभावित एक्वीजीशन की फ़ंडिंग और वर्किंग कैपिटल ज़रूरतों को पूरा करने के लिए

Akums Drugs IPO के बाद

[{"selector":"#anim-e32f46ea-3f97-40ed-87cc-b1cdbcc12b48","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-50db0415-51db-4262-9cf2-8076269b092f","keyframes":{"transform":["translate3d(-115.18988%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bc0d3924-cb64-4099-a369-d1d7940cef33","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-be9d9edf-2863-42df-b5bf-6f6070bc1a62","keyframes":{"transform":["translate3d(-112.68882%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] 10685 नेट वर्थ (करोड़ ₹) 1470 प्रमोटर होल्डिंग (%) 75.3 प्राइस/अर्निंग रेशियो (P/E) 13356 प्राइस/बुक रेशियो (P/B) 7.3 मार्केट कैप (करोड़ ₹)

Akums Drugs की फ़ाइनेंशियल हिस्ट्री

[{"selector":"#anim-44576e70-e9d8-440c-bbb3-0305ee29a181","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-96b0b1fb-e02d-4e49-b6ca-808b8d3e175a","keyframes":{"transform":["translate3d(-115.18988%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] EBIT-- अर्निंग बिफ़ोर इंटरेस्ट एंड टैक्स PAT -- प्रॉफ़िट आफ्टर टैक्स फ़ाइनेंशियल्स (करोड़ ₹) 2Y ग्रोथ (% सालाना) FY24 FY23 FY22 रेवेन्यू 6.7 4178 3655 3672 EBIT - -2 225 -186 PAT - 1 98 -251 नेट वर्थ 709 717 622 कुल डेट 567 618 394

Akums Drugs के अहम रेशियो

[{"selector":"#anim-e638ced2-e263-46ed-b218-17998bc2121f","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8cd1852e-0768-4ed9-9f71-aba7e1dcb7a1","keyframes":{"transform":["translate3d(-116.4557%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-fc803927-9260-4cd1-adec-5711f56fbf1a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c644cf3f-cd4a-4d65-94cb-69a47234c049","keyframes":{"transform":["translate3d(-112.83582%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] 3 साल का औसत (%) FY24 FY23 FY22 ROE (%) -8.8 0.11 13.5 -40.1 ROCE (%) 3 3.4 24.6 -18.9 EBIT मार्जिन (%) 0.4 -0.1 6.2 -5.1 डेट-टू-इक्विटी 0.8 0.9 0.6 रेशियो ROE -- रिटर्न ऑन इक्विटी ROCE -- रिटर्न ऑन कैपिटल एम्प्लॉयड

आपको यह भी पसंद आ सकती हैं

₹2,000 की SIP कितनी वेल्थ बनाएगी 20 साल में? SIP से मिलने वाले रिटर्न पर कितना टैक्स लगता है? बेटी के लिए SIP ज़रिए कहां निवेश करें? SIP के 5 मंत्र जिनमें है आपको करोड़पति बनाने का दम

Akums Drugs की पॉज़िटिव बात

[{"selector":"#anim-4af32581-a63e-4457-ac4b-bbb0db0d08fe [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(0%, 0, 0) translate(25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-3b23a600-0189-4b5b-b031-2f6eeabe51f8","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cea44147-9ba8-4aa7-8e16-7f37386f3f99","keyframes":{"transform":["translate3d(-115.50632%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-547397e6-d43c-42cb-9b15-8c74e7e8f417","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-65b3c09a-33ed-422c-b995-192a26a392fa","keyframes":{"transform":["translate3d(-115.50632%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] बड़ा साइज़ और क्षमता: कंपनी का साइज़ और क्षमता इसकी सबसे बड़ी ताक़त है. ये अपनी 11 मैन्युफैक्चरिंग फैसिलिटी के ज़रिए सालाना लगभग 50 बिलियन फ़िनिश्ड डोसेज़ बना सकती है. ये सबसे बड़ी इंडिया-फ़ोकस्ड CDMO कंपनी है, और ख़ास तौर से भारतीय फ़ार्मा कंपनियों के लिए जेनेरिक दवाएं बनाती है.

Akums Drugs की नेगेटिव बात

[{"selector":"#anim-a3144ace-3e4a-48d0-b6e0-5e01e5701e65 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(0%, 0, 0) translate(25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-be564091-a91d-4aae-ab89-aa7c397e51df","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6c7bb060-794d-4ae1-9c22-dce875fbd2a4","keyframes":{"transform":["translate3d(-115.50632%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3be63638-968f-4f15-901a-010f7068df93","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-549f2736-267b-4254-96cf-a1fa41bbc8b9","keyframes":{"transform":["translate3d(-115.50632%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] इंडस्ट्री के सख़्त नियम: फ़ार्मा इंडस्ट्री को नियमों का बहुत ज़्यादा पाबंध रहना पड़ता है, और कोई भी लापरवाही या नियमों की अनदेखी कंपनी के ऑपरेशन पर गंभीर असर डाल सकती है. क्यों रहें IPO से दूर?

क्या Akums Drugs का पिछले 12 महीनों में profit before tax ₹50 करोड़ से ज़्यादा है?

[{"selector":"#anim-165afe0e-cd0a-424f-9bc1-c54304aad4c3 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(0%, 0, 0) translate(25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-b358854b-4bc5-4ab9-bc99-7e004ba3cd2e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-27740079-6e7f-4ffe-8e55-1ef5e38ef13d","keyframes":{"transform":["translate3d(-114.63415%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-533b70b1-bc1d-440e-b3a1-e3b199c41fcd","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cae0095f-43a0-42b2-9e5d-139c7996c2bf","keyframes":{"transform":["translate3d(-115.18988%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] नहीं. कंपनी ने FY24 में ₹45 करोड़ का घाटा (टैक्स से पहले) दर्ज़ किया है.

डिस्क्लेमर

[{"selector":"#anim-5e82b01b-41dc-4291-b179-c9fa4798279d [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(0%, 0, 0) translate(25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-8851f2fb-5104-4914-acbc-b6345d06098e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-92cda905-d0ec-42c6-826e-b02a1e5afee0","keyframes":{"transform":["translate3d(-115.2439%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-043fcd3f-462c-474c-a45b-16d7b380b5a4","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b3d60b6b-3498-40b3-85f0-d9cb8f8ce3ec","keyframes":{"transform":["translate3d(-115.82278%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] ये लेख IPO से जुड़ी जानकारी देने के लिए है. इसे निवेश की सलाह न समझें. ज़्यादा जानकारी के लिए अगली स्लाइड में दिए गए लिंक पर जाएं और धनक के “IPO अनालेसिस” आर्टिकल को पढ़ें.